mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.2 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.2 |